Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has received a consensus recommendation of “Hold” from the fourteen brokerages that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and seven have given a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $14.2083.
A number of research firms have recently issued reports on ARDT. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a research report on Friday, June 12th. Royal Bank Of Canada dropped their price target on Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, March 9th. Wall Street Zen upgraded Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Leerink Partners dropped their price target on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Finally, Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th.
Get Our Latest Analysis on Ardent Health
Insider Buying and Selling
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd lifted its holdings in Ardent Health by 1,177.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after acquiring an additional 2,638 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in Ardent Health in the third quarter valued at approximately $61,000. New York State Common Retirement Fund lifted its holdings in Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares during the last quarter. Monetary Solutions Ltd acquired a new position in Ardent Health in the fourth quarter valued at approximately $79,000. Finally, Abel Hall LLC acquired a new position in Ardent Health in the first quarter valued at approximately $87,000.
Ardent Health Price Performance
NYSE:ARDT opened at $9.11 on Thursday. Ardent Health has a 12 month low of $7.71 and a 12 month high of $15.48. The stock has a 50 day moving average of $9.51 and a two-hundred day moving average of $9.13. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. The firm has a market cap of $1.31 billion, a P/E ratio of 9.58, a price-to-earnings-growth ratio of 2.10 and a beta of 0.84.
Ardent Health (NYSE:ARDT – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.18 by $0.10. The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, analysts expect that Ardent Health will post 1.11 earnings per share for the current fiscal year.
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Read More
- Five stocks we like better than Ardent Health
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
